Promising combo therapy for multiple myeloma shows potential in early trial
NCT ID NCT02405364
First seen Apr 16, 2026 · Last updated Apr 25, 2026 · Updated 2 times
Summary
This study tested a three-drug combination (carfilzomib, lenalidomide, and dexamethasone) given before and after a stem cell transplant in 46 newly diagnosed multiple myeloma patients aged 65 or younger. The goal was to see how many patients achieved a very deep remission after the full treatment plan. Results will help decide if this approach should be tested in larger trials.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHRU Dijon
Dijon, France
-
CHRU Hôtel Dieu
Nantes, France
-
CHU Grenoble
Grenoble, France
-
CHU Henri Mondor
Créteil, France
-
CHU de Toulouse
Toulouse, 31000, France
-
Hôpital Bretonneau
Tours, France
-
Hôpital Claude Huriez
Lille, France
-
Hôpital Saint-Antoine
Paris, France
-
Hôpital de Hautepierre
Strasbourg, France
-
Hôpital de Pontchaillou
Rennes, France
-
University hospital of Toulouse
Toulouse, 31000, France
Conditions
Explore the condition pages connected to this study.